Answers are grounded in this paper and cite their sources.
Infected diabetic wounds are characterized by a long disease course, difficulty in healing, high recurrence rate, and high mortality rate. Effective therapeutic strategies to eliminate infection and simultaneously promote wound healing are critically needed. Here, this work constructed an efficient nanoplatform (Lev-Arg@Ca NPs) to accelerate wound healing via arginine (Arg)-calcium (Ca 2+ ) co-activation of TREM2+ Mac combined with anti-infection of levofloxacin (Lev). Local administration of Arg and Ca 2+ promotes the expression of TREM2+ Mac via arginase 1 and u-calpain mediated macrophage differentiation. Then, the PI3K-Akt signaling pathway is activated via both the TREM2-DAP12-SYK axis and the SPP1-CD44 interaction, regulating anti-inflammation, angiogenesis, and tissue remodeling via downstream NF-κB, STAT3, and mTOR signaling axes. On one hand, the inhibition of the NF-κB pathway reduces the secretion of chemokines such as CCL2, CCL7, and CXCL2, alleviating persistent inflammation in infected diabetic wounds. On the other hand, activation of the STAT3 pathway promotes VEGF expression, facilitating angiogenesis. Meanwhile, activation of the PI3K/Akt/mTOR pathway enhances HIF-1α expression, strengthening intercellular communication and tissue remodeling in the infected diabetic wound microenvironment. These three pathways, together with the bactericidal effect, work in a combined manner to promote rapid and efficient healing of infected diabetic wounds. Overall, this study provides a promising strategy for effective treatment of infected diabetic wounds via specific TREM2+ Mac activation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: